AI drug research company pioneering anti-cancer therapeutics, anti-fibrosis small molecule drugs, Smad/Smad3 inhibition, and combination cancer-fibrosis therapies
About Company-
Moexa is an early stage multi-national drug research and development company with proprietary TGF-β/Smad3, AI designed, small molecule anti-cancer and anti-fibrosis therapeutic. Moexa’s SMAD3 TGF-β prevents cancer and fibrosis.
Click Here For More Info:- https://moexa.com/
Social Media Profile Links:-
https://www.linkedin.com/company/moexa/?originalSubdomain=hk
